NEW YORK (Reuters) - As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on Friday, Wall Street ...

Pharmacies prescribe big changes, Apple and Nvidia keep tech stocks rally going, canceling subscriptions gets easier ...

In a tight, historically expensive presidential election, both candidates are seeking the support of powerful business ...

While rates, risk adjustment and the IRA are exerting pressure on Medicare Advantage, CVS Health has some "self-induced" ...

Karen Lynch frequently spoke of how her mother's death from suicide and her aunt's death from cancer shaped her health care ...

Walgreens also has over $20 billion of long-term leases, primarily stores. Although these don’t have to be funded in the same way as borrowings in a buyout, they are another call on its cashflow. At ...

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

For three years in a row, Karen Lynch was ranked No. 1 on Fortune's Most Powerful Women list. Her job as CEO of CVS Health ...

David Joyner will take over as the company heads in a new direction to stabilize its finances. CVS Health’s reshuffling has ...

CVS Health has appointed David Joyner as its new CEO, following the company’s ongoing financial challenges and missed ...